Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Monica E. Kleinman, M.D.

Co-Author

This page shows the publications co-authored by Monica Kleinman and Leslie Gordon.
Connection Strength

1.803
  1. Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome. JAMA. 2018 04 24; 319(16):1687-1695.
    View in: PubMed
    Score: 0.189
  2. Survey of plasma proteins in children with progeria pre-therapy and on-therapy with lonafarnib. Pediatr Res. 2018 05; 83(5):982-992.
    View in: PubMed
    Score: 0.187
  3. Ophthalmologic Features of Progeria. Am J Ophthalmol. 2017 Oct; 182:126-132.
    View in: PubMed
    Score: 0.180
  4. Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome. Circulation. 2016 Jul 12; 134(2):114-25.
    View in: PubMed
    Score: 0.167
  5. The decision-making process and criteria in selecting candidate drugs for progeria clinical trials. EMBO Mol Med. 2016 07; 8(7):685-7.
    View in: PubMed
    Score: 0.167
  6. Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome. Circulation. 2014 Jul 01; 130(1):27-34.
    View in: PubMed
    Score: 0.144
  7. Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment. Neurology. 2013 Jul 30; 81(5):427-30.
    View in: PubMed
    Score: 0.136
  8. Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2012 Oct 09; 109(41):16666-71.
    View in: PubMed
    Score: 0.129
  9. Mechanisms of premature vascular aging in children with Hutchinson-Gilford progeria syndrome. Hypertension. 2012 Jan; 59(1):92-7.
    View in: PubMed
    Score: 0.121
  10. New approaches to progeria. Pediatrics. 2007 Oct; 120(4):834-41.
    View in: PubMed
    Score: 0.091
  11. Skeletal maturation and long-bone growth patterns of patients with progeria: a retrospective study. Lancet Child Adolesc Health. 2020 04; 4(4):281-289.
    View in: PubMed
    Score: 0.054
  12. Microbiome at sites of gingival recession in children with Hutchinson-Gilford progeria syndrome. J Periodontol. 2018 06; 89(6):635-644.
    View in: PubMed
    Score: 0.048
  13. Cardiac Abnormalities in Patients With Hutchinson-Gilford Progeria Syndrome. JAMA Cardiol. 2018 04 01; 3(4):326-334.
    View in: PubMed
    Score: 0.047
  14. Pubertal Progression in Female Adolescents with Progeria. J Pediatr Adolesc Gynecol. 2018 Jun; 31(3):238-241.
    View in: PubMed
    Score: 0.046
  15. Initial cutaneous manifestations of Hutchinson-Gilford progeria syndrome. Pediatr Dermatol. 2014 Mar-Apr; 31(2):196-202.
    View in: PubMed
    Score: 0.035
  16. A prospective study of radiographic manifestations in Hutchinson-Gilford progeria syndrome. Pediatr Radiol. 2012 Sep; 42(9):1089-98.
    View in: PubMed
    Score: 0.032
  17. Hutchinson-Gilford progeria is a skeletal dysplasia. J Bone Miner Res. 2011 Jul; 26(7):1670-9.
    View in: PubMed
    Score: 0.030
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.